PHS
EDIT icon

PFM Health Sciences’s Editas Medicine EDIT Stock Holding History

PFM Health Sciences’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-82,281
Closed -$642K – 71
2023
Q3 		$642K Sell
82,281
-358,889
-81% -$3.08M 0.03% 71
2023
Q2 		$3.63M Sell
441,170
-599,624
-58% -$5.22M 0.14% 72
2023
Q1 		$7.55M Sell
1,040,794
-425,938
-29% -$3.79M 0.33% 60
2022
Q4 		$13M Buy
1,466,732
+187,678
+15% +$2.06M 0.47% 62
2022
Q3 		$15.7M Buy
1,279,054
+649,370
+103% +$10.1M 0.57% 56
2022
Q2 		$7.45M Buy
+629,684
New +$8.44M 0.28% 66
2021
Q1 		– Sell
-29,900
Closed -$2.1M – 95
2020
Q4 		$2.1M Buy
+29,900
New +$1.23M 0.07% 83

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PFM Health Sciences's EDIT Position: Q4 2023 in Review

PFM Health Sciences sold out of Editas Medicine (EDIT) in Q4 2023, closing a stake of 82,281 shares — an estimated $642K sold.

PFM Health Sciences first reported a position in EDIT in Q4 2020 and held it in 7 quarters. The position peaked at $15.7M in Q3 2022. 225 funds tracked by Wall St. Rank hold EDIT as of Q4 2023.

  • PFM Health Sciences reported no remaining Editas Medicine position as of Q4 2023 after selling out during the quarter.
  • PFM Health Sciences sold 82,281 Editas Medicine shares in Q4 2023, an estimated $642K.
  • PFM Health Sciences first reported a position in Editas Medicine in Q4 2020 and held it in 7 quarters.
  • PFM Health Sciences's Editas Medicine position peaked at $15.7M in Q3 2022.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2023.

Based on PFM Health Sciences's 13F filing for Q4 2023, filed 14 Feb 2024.